Page 51 - Bioscience Inc News Today

Todd Nelson, CEO, describes Codex DNA (NASDAQ:DNAY) in this 1,921 word interview, exclusively in the Wall Street Transcript.

A genetically modified organism (GMO) is developed by utilizing genetic engineering techniques that modify an organism’s genetic structure, with genes that can be crossed among different species or ...

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

/PRNewswire/ -- The "Bio-based Platform Chemicals Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been...

ABL Advisor provides a unique view of the world of commercial equipment finance by focusing content and resources on both sides of the equipment finance spectrum – the lender and lessor as well as the borrower and lessee. Our goal is to meet the editorial content needs of both participants in an equipment finance transaction resulting in greater opportunities for long-term relationships between the two parties.

INVO Bioscience (NASDAQ:INVO – Get Rating)‘s stock had its “buy” rating reissued by Colliers Securities in a report released on Tuesday, Zacks.com reports. INVO has been the subject of a number of other reports. Maxim Group started coverage on shares of INVO Bioscience in a report on Wednesday, January 19th. They set a “buy” rating […]

Recombinant Protein Market Analysis by Product Type (Chemokines, Immune Checkpoint Regulators, Growth Factors, Cytokines, Colony Stimulating Factors,...

Clarus Securities restated their buy rating on shares of TerrAscend (OTCMKTS:TRSSF – Get Rating) in a report published on Thursday morning, Zacks.com reports. A number of other research firms have also weighed in on TRSSF. Stifel Nicolaus lowered their price objective on shares of TerrAscend from C$23.00 to C$21.00 and set a buy rating for […]

Zacks Investment Research cut shares of Yield10 Bioscience (NASDAQ:YTEN – Get Rating) from a hold rating to a sell rating in a research note published on Tuesday morning, Zacks.com reports. According to Zacks, “Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to […]

The Apothecarium, a new app on the Apple App Store, lets users in New Jersey and California place orders from their dispensaries.